Statement Of Financial Position [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183077

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	40,717,000 EUR	—	—	—	—	38,354,000 EUR	—	—	—	—	—	—	—	—	—
Right-of-use assets	65,534,000 EUR	—	—	—	—	69,322,000 EUR	—	—	—	—	—	—	—	—	—
Goodwill	5,233,000 EUR	—	—	—	—	5,233,000 EUR	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	134,905,000 EUR	—	—	—	—	104,954,000 EUR	—	—	—	—	—	—	—	—	—
Deferred tax assets	16,354,000 EUR	—	—	—	—	63,456,000 EUR	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	28,285,000 EUR	—	—	—	—	32,872,000 EUR	—	—	—	—	138,675,000 EUR	—	—	—	—
Assets	442,414,000 EUR	—	—	—	—	421,918,000 EUR	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	41,228,000 EUR	—	—	—	—	32,250,000 EUR	—	—	—	—	—	—	—	—	—
Retained earnings	396,254,000 EUR	—	—	—	—	336,633,000 EUR	—	—	—	—	—	—	—	—	—
Other reserves	19,934,000 EUR	—	—	—	—	2,545,000 EUR	—	—	—	—	—	—	—	—	—
Equity	33,687,000 EUR	396,254,000 EUR	41,228,000 EUR	19,934,000 EUR	408,647,000 EUR	33,840,000 EUR	336,633,000 EUR	2,545,000 EUR	340,769,000 EUR	32,250,000 EUR	157,737,000 EUR	31,271,000 EUR	219,759,000 EUR	13,690,000 EUR	332,535,000 EUR
Liabilities [abstract]
Deferred tax liabilities	4,420,000 EUR	—	—	—	—	6,089,000 EUR	—	—	—	—	—	—	—	—	—
Equity and liabilities	442,414,000 EUR	—	—	—	—	421,918,000 EUR	—	—	—	—	—	—	—	—	—